Morgan Stanley downgrades Johns Lyng Group Ltd (JLG) to a Hold
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
According to TipRanks, Wang is ranked #2861 out of 9822 analysts.
Johns Lyng Group Ltd has an analyst consensus of Hold, with a price target consensus of A$4.00, implying a 2.83% upside from current levels. In a report released yesterday, Jefferies also downgraded the stock to a Hold with a A$4.00 price target.
Based on Johns Lyng Group Ltd's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of A$573.13 million and a net profit of A$14.47 million. In comparison, last year the company earned a revenue of A$610.6 million and had a net profit of A$23.36 million
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
36 minutes ago
- Yahoo
Morgan Stanley Maintains a Buy on Exelixis (EXEL) With a $48 PT
Exelixis, Inc. (NASDAQ:EXEL) is one of the most profitable biotech stocks to invest in now. On July 22, Morgan Stanley analyst Sean Laaman maintained a Buy rating on Exelixis, Inc. (NASDAQ:EXEL) and set a price target of $48.00. A team of scientists in lab coats surrounded by pharmaceuticals and medical equipment, researching a life-saving oncology-focused biotechnology. The analyst reasoned that Exelixis, Inc. (NASDAQ:EXEL) recently updated its 2025 revenue guidance, increasing it to a $2.25-2.35 billion range after the higher-than-expected sales of Cabo. He attributed this optimistic outlook to the persistent demand growth and new patient starts in first-line renal cell carcinoma (1L RCC). Laaman also stated that Exelixis, Inc. (NASDAQ:EXEL) reported that it may update its guidance further as the NET launch progresses and additional revenue opportunities become clearer. Exelixis, Inc. (NASDAQ:EXEL) discovers, develops, and commercializes new medicines for difficult-to-treat cancers. Its product portfolio includes cabometyx, cometriq, and cotellic. While we acknowledge the potential of EXEL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Business Insider
an hour ago
- Business Insider
Suncorp Group (SNMYF) Gets a Hold from Citi
In a report released today, Nigel Pittaway from Citi maintained a Hold rating on Suncorp Group, with a price target of A$22.40. The company's shares closed last Friday at $10.83. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Pittaway covers the Financial sector, focusing on stocks such as ASX , Insurance Australia Group Limited, and AMP . According to TipRanks, Pittaway has an average return of 3.4% and a 56.50% success rate on recommended stocks. In addition to Citi, Suncorp Group also received a Hold from TR | OpenAI – 4o's Wesley Roofguard in a report issued on July 26. However, on July 25, Morgan Stanley maintained a Buy rating on Suncorp Group (Other OTC: SNMYF). The company has a one-year high of $17.99 and a one-year low of $10.37. Currently, Suncorp Group has an average volume of 531.
Business Insider
an hour ago
- Business Insider
Alibaba Cloud founder says early innovation doesn't need top-dollar hires: 'What happened in Silicon Valley is not the winning formula'
True innovation doesn't come from highly paid engineers, but from finding the right people to build the unknown, said the founder of Alibaba's cloud and AI unit. "The only thing you need to do is to get the right person," Wang Jian said in an interview with Bloomberg published Monday. "Not really the expensive person because if it's a new business, if it's true innovation, that basically means talent," he added. Wang, who built Alibaba Cloud in 2009, said American tech giants are "very much focused on the existing success of the business." "And existing — it's average of technology," the computer scientist said. "We have a tremendous opportunity to look at technology nobody knows today." "What happened in Silicon Valley is not the winning formula," Wang said. Wang's comments come after Big Tech companies are paying top dollar to recruit elite AI talent, a trend that's likened to sports franchises competing for superstar athletes like Cristiano Ronaldo. The competition reached another level when Meta recruited Scale's CEO, Alexandr Wang, last month as part of a $14.3 billion deal to take a 49% stake in his company. Then, Sam Altman, the CEO of OpenAI, said Meta had tried to poach his best employees with $100 million signing bonuses. Just weeks ago, Google paid $2.4 billion to hire the CEO and top talent of AI startup Windsurf and license its intellectual property. OpenAI had planned to buy Windsurf for $3 billion, but the deal fell apart. "It's a typical way of doing things," Wang Jian said of Big Tech's hiring strategy. Chasing the same pool of in-demand talent isn't always a winning move, he added. "Whenever everybody knows that these are talents," Wang said, "it's better for you not to get it." "It's really about the vision, you know, where you want to go." Wang and Alibaba did not respond to a request for comment from Business Insider. China's AI race is 'very healthy' competition Wang also said that the rivalry among Chinese AI firms is not cutthroat. No single person or company can sprint forever, he said. But collectively, the ecosystem can still move fast. He pointed to a pattern he's observed: One company surges ahead, then slows. Then another takes the lead. Over time, the first catches up again. "You can have the very fast iteration of the technology because of this competition," he said. "I don't think it's brutal, but I think it's very healthy," he added. China's biggest tech players have focused on open-source AI models, which have code and architecture that are publicly available for anyone to use, modify, or build on. One analyst told Business Insider previously that Chinese firms are prioritizing consolidation to stay competitive. For instance, Tencent has deployed its Hunyuan model and DeepSeek R1 across its massive ecosystem, including WeChat. Baidu has also integrated DeepSeek R1 into its search engine. The country is closing the gap with the US in the AI race. In a Stratechery interview earlier this year, Nvidia's CEO, Jensen Huang, said that China is doing "fantastic" in the AI market, with homegrown models like DeepSeek and Manus emerging as credible challengers to US-built systems. He said China's AI researchers are some of the best in the world, and it's no surprise that US companies like OpenAI and Anthropic are hiring them. "Our competition in China is really intense," Huang said in May at the Computex Taipei tech conference in Taiwan. Huang has also said that the US and China are neck and neck in the AI chip race. "China is right behind us. We're very, very close."
